LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, ...
(November 24, 2011) - Sunnybrook's Dr. Robert Nam and the University of Toronto's Dr. Shana Kelley have struck a partnership that may transform prostate cancer screening as we know it. Backed by a ...
Transrectal ultrasound-guided biopsy is a widely accepted procedure in prostate cancer diagnosis, although little is known about the effects on the detection rate of different types of ultrasound ...